New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Guardant Health, Inc.
GH
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3B

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

3B

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

22.20USD
Shape1.69 ( 8.24%)
favorite-chart

Relative Strenght

89
favorite-chart

Volume Buzz

-22%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated October 28, 2024
1W 9.09 % 1M -3.23 % 3M -37.07 % 1Y -12.36 %

Key Metrics

Shape
  • Market Cap

    2.73B


  • Shares Outstanding

    123.02M


  • Share in Float

    117.72M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    22.2


  • Average Volume

    2.28M


  • Beta

    1.108


  • Range

    15.81-37.04


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://guardanthealth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

4.24x

P/S Ratio

-1685.26x

P/B Ratio

-724.7

Debt/Equity

-76.2%

Net Margin

$-4.1

EPS

How GH compares to sector?

P/E Ratio

Relative Strength

Shape

GH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$823M

Shape364%

2025-Revenue

$2.81

Shape-234%

2025-EPS

$672M

Shape-647%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Guggenheim

upgrade

Previous: Not converted

2024-06-28

Now: Buy

Jefferies

initialise

Previous: Not converted

2024-06-03

Now: Buy

Raymond James

upgrade

Previous: Not converted

2023-11-13

Now: Outperform

Piper Sandler

initialise

Previous: Not converted

2023-05-26

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.58
vs -1.06

Q4.22

arrow
arrow

N/A

-1.36
vs -0.89

Q1.23

arrow
arrow

N/A

-1.30
vs -1.21

Q2.23

arrow
arrow

N/A

-0.67
vs -2.25

Q3.23

arrow
arrow

N/A

-0.73
vs -1.58

Q4.23

arrow
arrow

N/A

-1.58
vs -1.36

Q1.24

arrow
arrow

N/A

-0.46
vs -1.30

Q2.24

arrow
arrow

N/A

-0.48
vs -0.67

Q3.24

arrow
arrow

N/A

-0.74
vs -0.73

Q4.24

arrow
arrow

N/A

-0.72
vs -1.58

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+24%

117.4M  vs 94.8M

Q4.22

arrow
arrow

+17%

126.9M  vs 108.1M

Q1.23

arrow
arrow

+34%

128.7M  vs 96.1M

Q2.23

arrow
arrow

+26%

137.2M  vs 109.1M

Q3.23

arrow
arrow

+22%

143M  vs 117.4M

Q4.23

arrow
arrow

+22%

155.1M  vs 126.9M

Q1.24

arrow
arrow

+31%

168.5M  vs 128.7M

Q2.24

arrow
arrow

+29%

177.2M  vs 137.2M

Q3.24

arrow
arrow

+19%

170.5M  vs 143M

Q4.24

arrow
arrow

+17%

180.6M  vs 155.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-97%

-0.97
vs -0.72

Q4.22

arrow
arrow

-233%

-2.33
vs -0.97

Q1.23

arrow
arrow

+300%

3
vs -2.33

Q2.23

arrow
arrow

-25%

-0.25
vs 3

Q3.23

arrow
arrow

-38%

-0.38
vs -0.25

Q4.23

arrow
arrow

-118%

-1.18
vs -0.38

Q1.24

arrow
arrow

-168%

-1.68
vs -1.18

Q2.24

arrow
arrow

+6363%

63.63
vs -1.68

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

359

359
vs 348

3%

Q4.22

arrow
arrow

318

318
vs 359

-11%

Q1.23

arrow
arrow

295

295
vs 318

-7%

Q2.23

arrow
arrow

312

312
vs 295

6%

Q3.23

arrow
arrow

306

306
vs 312

-2%

Q4.23

arrow
arrow

313

313
vs 306

2%

Q1.24

arrow
arrow

288

288
vs 313

-8%

Q2.24

arrow
arrow

305

305
vs 288

6%

Earnings Growth

Latest News